Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Biosimilar-Product'
Biosimilar-Product published presentations and documents on DocSlides.
Building a Biosimilars Pathway in the U.S.
by attentionallianz
Richard . Dolinar. , MD. Endocrinologist, Chairman...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by calandra-battersby
OMIC Group Biosimilars 2014. Hyderabad India. 27-...
Comparison of US/EU Biosimilar
by aaron
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Comparison of US/EU Biosimilar
by myesha-ticknor
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Biosimilar Biological Products
by luanne-stotts
2016 . Clinical Investigator . Training Course. S...
Comparison of US/EU Biosimilar
by danika-pritchard
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by stefany-barnette
OMIC Group Biosimilars 2014. Hyderabad India. 27-...
PhAMA Position on Biosimilar Medicines
by celsa-spraggs
Ms. Leah Goodman. Contents. Key Messages. An Over...
ASBM Biosimilars
by phoebe-click
US Prescribers and Biosimilars Naming. Kevin Olso...
Synergy Satellite Event - Biosimilars in colorectal cancer
by mia
– what's your gut feeling?. 25th Anniversary EAH...
The generic and biosimilar
by alida-meadow
perspective. Warwick Smith. Director General BGMA...
Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS
by myesha-ticknor
Dr Chris Deighton. Consultant Rheumatologist . Co...
U.S. Biosimilars: An Introduction
by calandra-battersby
Disclaimers. :. By 2016, 7 of the top 10 pharmace...
MODULE 8. Follow-on drugs: generic, biosimilar
by alida-meadow
& non-biological similar medicinal products ....
Latin American Biologics/Biosimilars Conference
by giovanna-bartolotta
Presented by . the Alliance for Safe Bioloigic . ...
Category 1: Defining Terms
by jasmine
Clue: . A biologic product with no clinically mean...
INSIGHTS INTO THE MARKET
by summer
FOR INFLIXIMABTable of ContentsThe Evolving Landsc...
22 MayEMACHMPBWP2477132012Committee for Medicinal Products for Hum
by carla
Adoption by CHMP for release for consultation24 Ma...
Phil Johnson MS RPh Safe School Meds, Principle Partner
by yoshiko-marsland
Moffitt Cancer Center, Director of Pharmacy (Reti...
Conference Series LLC Conferences
by mitsue-stanley
Conference Series LLC . is a pioneer and leading ...
Faculty Leonard H. Calabrese, DO
by trish-goza
Professor of Medicine. Cleveland Clinic Lerner Co...
Biological Products: concepts, naming,
by faustina-dinatale
interchangeability,extrapolation. and safety. Dr...
Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives
by alida-meadow
Richard Montes, Ph.D.. Hospira. , a Pfizer compan...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by calandra-battersby
OMICS Group Biosimilars 2015 Birmingham, UK. 10-1...
Conference Series LLC
by trish-goza
Conferences. Conference Series LLC . is a pioneer...
Phil Johnson MS
by stefany-barnette
RPh. Safe School Meds, Principle Partner. Moffitt...
Biosimilars in the united states – Update on FDA Impleme
by test
James C. Shehan. Hyman, Phelps & McNamara, P....
JMP for Biosimilars : Tools for Analytical Similarity
by erica
Sept 16, 2015. W. Heath Rushing, . Adsurgo. LLC. ...
US Regulatory Pathway For Biosimilars
by cheryl-pisano
Practical Legal/Regulatory Considerations Arising...
Concurrent Session 1B
by yoshiko-marsland
View . from the Life Sciences . Industry. Moderat...
Biosimilars
by lindy-dunigan
Knowledge Connect Slide Resource. This slide dec...
What You Need to Know About
by marina-yarberry
Biosimilars. : Products, Recent Deals, IP Issues ...
Distinguishable INNs: A Global Solution
by trish-goza
Richard . Dolinar. , MD. Chairman, Alliance for S...
What is the value of Real-World Evidence for Biosimilars?
by bitsy
Disclaimer. This panel is moderated by Dr. Delphin...
Budget impact and cost-effectiveness of oncology
by roxanne
biosimilars. Prof. dr. Steven Simoens. Health econ...
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
by iamamercy
Dr.G.Hima. . Bindu. ...
Bio similars A Presentation
by kittie-lecroy
By. ANSHUL . SHARMA. Graduate Research Scholar. D...
Application of Biosimilars in RA IN Clinical Practice:
by conchita-marotz
Key Issues and Challenges. . Introduction. Diff...
United Spinal Association
by alida-meadow
August, 2014. Biologics & Biosimilars: . An O...
Applying Biosimilars in Hematologic Cancers
by conchita-marotz
This program will include a discussion of off-lab...
Load More...
